AngioDynamics Inc. (ANGO) Tops Q3 EPS by 3c, Provides FY11 Guidance
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $15.75 -0.44%
Financial Fact:
Research and development: 6.71M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development: 6.71M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
AngioDynamics Inc. (NASDAQ: ANGO) reported Q3 EPS of $0.15, $0.03 better than the analyst estimate of $0.12. Revenue for the quarter came in at $54.6 million versus the consensus estimate of $53.89 million.
AngioDynamics Inc. sees FY2011 EPS of $0.48-$0.50, versus the consensus of $0.49. AngioDynamics Inc. sees FY2011 revenue of $217-$220 million, versus the consensus of $220.2 million.
AngioDynamics Inc. sees FY2011 EPS of $0.48-$0.50, versus the consensus of $0.49. AngioDynamics Inc. sees FY2011 revenue of $217-$220 million, versus the consensus of $220.2 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
- Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
